...
首页> 外文期刊>Sexually transmitted diseases >Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination.
【24h】

Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination.

机译:与男性发生性关系的年轻男子中的病毒性肝炎:感染率,危险行为和疫苗接种。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Men who have sex with men (MSM) are at risk for acquiring hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). GOAL: The goal was to describe the seroprevalence of and risk factors for viral hepatitis, the frequency of vaccination against HAV and HBV, and reasons for lack of vaccination among young MSM. STUDY DESIGN: We performed hepatitis serologies on 833 MSM aged 15 to 29 years who attended public venues in King County, Washington. RESULTS: While 14.6% were HAV-immune due to vaccination, 13.9% had prior HAV infection; 57.9% were susceptible and 13.5% had unclear status. While 24.5% were HBV-immune due to vaccination, 13.3% had prior HBV infection; 44.2% were susceptible and 18.0% had unclear status. Prior HBV infection was associated with prior HAV infection. Men unvaccinated against HAV or HBV were unaware of the vaccines or had never been offered vaccination or perceived themselves at low risk for infection. Among 10 HCV-seropositive men, 70.0% reported injection drug use. CONCLUSION: MSM must be vaccinated at an early age to prevent acquisition of HAV and HBV. Given the frequency of coinfection with HAV and HBV, a combined vaccine would be useful in this population.
机译:背景:与男性发生性关系(MSM)的男性有感染甲型肝炎病毒(HAV),乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)的风险。目标:目标是描述病毒性肝炎的血清阳性率和危险因素,针对HAV和HBV的疫苗接种频率以及年轻MSM中缺乏疫苗接种的原因。研究设计:我们对15到29岁的833名MSM进行了肝炎血清学检查,他们参加了华盛顿金县的公共场所。结果:虽然有14.6%的人因疫苗接种而进行了HAV免疫,但13.9%的人先前有过HAV感染。 57.9%易感,13.5%的状态不明。尽管有24.5%的人因疫苗接种而对HBV免疫,但13.3%的人先前曾感染过HBV; 44.2%的人易感,状态不明的人为18.0%。先前的HBV感染与先前的HAV感染相关。未接种HAV或HBV疫苗的男性不知道该疫苗,或者从未接受过疫苗接种或认为自己感染风险低。在10例HCV血清反应阳性的男性中,有70.0%的人报告了注射毒品的使用。结论:MSM必须在早期接种,以防止获得HAV和HBV。考虑到与HAV和HBV合并感染的频率,联合疫苗将对该人群有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号